Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04853108 · ClinicalTrials.gov registry record
Remote Monitoring of COVID-19 Positive Outpatients
A clinical trial, sponsored by Emory University.
- Terminated
- Registry status
- 300
- Enrollment target
NCT04853108: Clinical Trial study, sponsored by Emory University.
NCT04853108 is a clinical trial that was terminated before completion, run by Emory University. The registered enrollment target is 300 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04853108 was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- 300 participants
- Enrollment target
Study Summary
This study seeks to evaluate how secondary data retrieved from remote physiological monitoring performed during routine outpatient/at-home care periods can allow for the discovery of novel physiomarkers that predict acute deterioration or hospitalization among people testing positive for Coronavirus Disease 2019 (COVID-19).
Primary Outcome
The Emory COVID-19 outpatient remote monitoring registry (E-CORMR) will be used to identify physiologic parameters and symptom responses that are associated with adverse outcomes.
Interventions
- OTHER Remote Monitoring of COVID-19
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2021-06-25 |
| Est. Completion | 2023-04-01 |
Why NCT04853108 stopped before completion
NCT04853108 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Remote Monitoring of COVID-19 is the first listed.
NCT04853108 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04853108 about?
NCT04853108 is a clinical study titled "Remote Monitoring of COVID-19 Positive Outpatients". This study seeks to evaluate how secondary data retrieved from remote physiological monitoring performed during routine outpatient/at-home care periods can allow for the discovery of novel physiomarkers that predict acute deterioration or hospitalization among people testing positive for Coronavirus...
What is the current status of trial NCT04853108?
This trial is currently terminated. The enrollment target is 300 participants. The study started on 2021-06-25. Estimated completion is 2023-04-01.
What interventions are being tested in trial NCT04853108?
The interventions under investigation include: Remote Monitoring of COVID-19 (OTHER).
Who is sponsoring clinical trial NCT04853108?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI